about
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcomeAspergillus citrinoterreus, a new species of section Terrei isolated from samples of patients with nonhematological predisposing conditionsImpact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data.Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.Micafungin at physiological serum concentrations shows antifungal activity against Candida albicans and Candida parapsilosis biofilms.Microsatellite (STRAf) genotyping cannot differentiate between invasive and colonizing Aspergillus fumigatus isolates.Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method.Rapid detection and identification of Aspergillus from lower respiratory tract specimens by use of a combined probe-high-resolution melting analysis.Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion MethodNew antifungal agents for the treatment of candidaemia.A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains.Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.The Etest Performed Directly on Blood Culture Bottles Is a Reliable Tool for Detection of Fluconazole-Resistant Candida albicans Isolates.Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates.Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia.Risk factors for late recurrent candidaemia. A retrospective matched case-control study.Clusters of patients with candidaemia due to genotypes of Candida albicans and Candida parapsilosis: differences in frequency between hospitals.Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method.Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation.Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.Outbreak of invasive aspergillosis after major heart surgery caused by spores in the air of the intensive care unit.Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.Fungaemia caused by rare yeasts: incidence, clinical characteristics and outcome over 10 years.Workload and clinical significance of the isolation of zygomycetes in a tertiary general hospital.Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital.Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs).Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates.Reduction in the percentage of clusters of Candida albicans and Candida parapsilosis causing candidemia in a general hospital in Madrid, Spain.Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in and species for the SYO colorimetric broth and Etest agar diffusion methodsMucormycosis: an emerging disease?Update on invasive aspergillosis: clinical and diagnostic aspectsgene point mutations are not antifungal resistance markers inResistance to Echinocandins in Candida Can Be Detected by Performing the Etest Directly on Blood Culture SamplesDetection of Echinocandin-Resistant Candida glabrata in Blood Cultures Spiked with Different Percentages of FKS2 Mutants
P50
Q28264458-C3A44078-AB3F-4023-A410-B6B00ECA38F1Q30877963-7B0DD41E-D23E-4379-A8F9-4EB12B6BE335Q31158496-DAABC386-0FD1-40C6-BAD1-46AC39A7B386Q33384785-52F92A67-A452-46E6-ACF3-69E50F28408AQ33773267-759FB164-F1F0-46FB-995D-BCDBC684BC03Q34057572-96014326-8FD5-41A9-B2E4-C46F5BAAC3B2Q34983239-45C89140-1B6A-48EA-BA66-16C65C928F29Q36158263-34CF0B37-2540-42A3-9174-D40D2C73172BQ36276996-03DAD679-7F04-40A7-9820-A80F375A7BB0Q36933366-4E5B5F91-E20B-488B-A983-F0D2AD675540Q36933437-32DE73A9-7BE2-45E7-BE7C-342E5ACA35F2Q37538775-88260046-013B-4E7A-AF04-AAB7CF70BC8FQ37815676-E4E87A47-1E45-4613-AA3C-025A241B783DQ39029924-0ECDE2D3-BC2D-4787-9624-71E4BA51BEF5Q39230127-C05D32D4-95AC-471B-8FED-80E6B243061EQ40220987-3238CB1D-E566-4CCF-B99E-D6F7CDB49980Q40239343-AE0B739E-E2EE-410B-A0EB-AB82A1940291Q40441738-CBA0C9C9-CFAA-4621-A395-44E7E477449BQ40525563-A435CE69-A6DC-4AB1-AAE5-AD510B69881FQ40918232-55900731-4062-4CE2-B4D3-50EE7D384DE4Q41325938-275202E7-376D-41C4-B97A-B47B7F2A157FQ41702288-91D06F8E-C4F4-4559-8646-B621B8652B9AQ41847739-C606E291-17B5-435C-941B-E942CCDD34D7Q42331366-8FCEB54D-26A3-4626-82EF-3A8752A31E40Q44010583-5BE5B9AB-C780-4DC8-B410-723511511E37Q44814572-08B0166B-40AA-4731-9260-2C644708CE18Q46176826-3E2CEDA7-7AC4-43A7-8279-5EFB3D77DEB4Q46244854-C98CCF00-0BF3-4673-9773-D870F3220657Q46546680-BB5E39A9-A07C-4C66-9390-A3F1177B4264Q46701510-D80B4410-9239-46E9-B829-27EF229E9924Q50044341-633BE2CA-0CFF-4826-9F40-ECC17D41DD6BQ50134184-51FA1315-FC8C-485C-A790-9E7B892AB994Q54216859-195D2439-D8E4-4131-9E24-2B0128AF442DQ57461270-BC535D20-8F10-4655-8112-D2B70716F6DCQ57569311-7CC3F336-B917-4BEC-86BA-23AB7CBA734AQ57569316-A20000DE-18C0-443D-8263-7C042AEB4ACDQ58609290-B5BEE4D0-4F29-4133-9619-8126C764963AQ60860358-19E7004B-E720-43E8-A46E-ACE7D86BF79AQ90594907-4DC3697E-7BF9-4E3A-8D8A-73CAC23046D9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jesus Guinea
@ast
Jesus Guinea
@en
Jesus Guinea
@es
Jesus Guinea
@nl
Jesus Guinea
@sl
type
label
Jesus Guinea
@ast
Jesus Guinea
@en
Jesus Guinea
@es
Jesus Guinea
@nl
Jesus Guinea
@sl
altLabel
Jesus Guinea
@en
prefLabel
Jesus Guinea
@ast
Jesus Guinea
@en
Jesus Guinea
@es
Jesus Guinea
@nl
Jesus Guinea
@sl
P1053
G-3083-2014
P106
P21
P31
P3829
P496
0000-0002-7901-8355